Lam, Ivan Chun Hang;
Chai, Yi;
Man, Kenneth Keng Cheung;
Lau, Wallis Cheuk Yin;
Luo, Hao;
Lin, Xiaoyu;
Yin, Can;
... Wong, Ian Chi Kei; + view all
(2025)
The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae following COVID-19 infection: a multinational network cohort study.
Journal of the Royal Society of Medicine
(In press).
Preview |
Text (Article)
Man_R2_ Clean_Main text.pdf - Accepted Version Download (665kB) | Preview |
Preview |
Text (Supplementary materials)
Man_R2_Supplementary materials.pdf - Accepted Version Download (19MB) | Preview |
Preview |
Text
Man_R2_T1A_US_Pharm_Combine_split_T2.pdf - Accepted Version Download (194kB) | Preview |
Preview |
Text
Man_R2_T1B_UKIMRD_Combine_split_T2.pdf - Accepted Version Download (78kB) | Preview |
Preview |
Text
Man_R2_T1C_France_combine_split_T2.pdf - Accepted Version Download (85kB) | Preview |
Preview |
Text
Man_R2_T1D_Germany_Combine_split_T2.pdf - Accepted Version Download (150kB) | Preview |
Preview |
Text
Man_R2_T1E_Italy_Combine_split_T2.pdf - Accepted Version Download (431kB) | Preview |
Abstract
Objectives: To generate comprehensive evidence on the risk of clinical sequelae involving different organ systems over time following COVID-19 infection. / Design: Multinational retrospective cohort study / Setting: Electronic medical records from the US, UK, France, Germany and Italy standardised to the Observational Medical Outcomes Partnership Common Data Model / Participants: 303,251 individuals with a COVID-19 infection between December 01, 2019 and December 01, 2020 and propensity score matched non-COVID-19 comparators from 22,108,925 eligible candidates / Main outcome measures: Incidence of 73 clinical sequelae involving multiple organ systems including the respiratory, cardiovascular, dermatological and endocrine systems over the short (0-6 months), medium (6-12 months) and long-term (1-2 years) following COVID-19 infection. The hazard ratio (HR) and 95% confidence interval (95% CI) of individual disease outcomes were estimated using Cox proportional hazard regression. / Results: Individuals with COVID-19 incurred a greater risk of clinical sequelae involving multiple organ systems including respiratory [France HR 2.23, 95%CI (2.10,2.37) to Italy 13.13 (11.80,14.63)], cardiovascular [Germany 1.39 (1.30,1.50) to US 1.79 (1.74,1.85)] and dermatological [UK 1.13 (1.01,1.25) to Italy 1.77 (1.42,2.21)] disorder over the short-term. Whilst the risk of clinical sequelae has largely subsided during the medium-term, the risk of cardiovascular [US 1.16 (1.11,1.21), France 1.10 (1.01,1.19)] and endocrine [US 1.18 (1.12,1.24), Germany 1.15 (1.03,1.29)] related complications may continue to persist for up to two years. / Conclusion: Through a network of multinational healthcare databases, this study generated comprehensive and robust evidence supporting the extensive multi-organ involvement of post-COVID-19 condition over the short-term period and the subside in risk for most complications over the medium and long-term.
| Type: | Article |
|---|---|
| Title: | The short-, medium- and long-term risk and the multi-organ involvement of clinical sequelae following COVID-19 infection: a multinational network cohort study |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://journals.sagepub.com/home/jrs |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | COVID-19; SARS-CoV-2; Post-COVID-19 conditions; Long COVID; Post-acute sequelae of SARS-CoV-2 |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Practice and Policy |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10211059 |
Archive Staff Only
![]() |
View Item |

